Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.
about
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.The establishment of KORCC (KOrean Renal Cell Carcinoma) database.Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria.
P2860
Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@ast
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@en
type
label
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@ast
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@en
prefLabel
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@ast
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@en
P2093
P2860
P356
P1433
P1476
Prognosis of Japanese patients ...... of molecular-targeted therapy.
@en
P2093
Katsunori Tatsugami
Masayuki Takahashi
Nobuo Shinohara
Sachiyo Murai
Seiji Naito
Takashige Abe
Tomomi Kamba
Wataru Obara
P2860
P304
P356
10.1111/CAS.12646
P50
P577
2015-03-19T00:00:00Z